By Topic

Tutorial sessions

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

An introduction to cancer modeling and control is followed by a description of the design of targeted drug therapies for cancer treatment. Recent efforts have been directed towards understanding why such therapies demonstrate very little anti-tumor activity for certain cancers. A class of tyrosine kinase inhibitors that target human epidermal growth factor receptors (HER) is unexpectedly inefficient in some cancers. A mathematical model for use in the study and treatment of cancers is described for the HER signaling pathway that agrees with the existing data over large time intervals. The mathematical model is used to understand the effects of applying certain drugs to such cancers and to determine a “steering-based” treatment scheme for cancers that over express.

Published in:

American Control Conference (ACC), 2010

Date of Conference:

June 30 2010-July 2 2010